Table of Contents Author Guidelines Submit a Manuscript
Journal of Spectroscopy
Volume 2013, Article ID 937409, 7 pages
http://dx.doi.org/10.1155/2013/937409
Research Article

Simple Spectrophotometric Methods for Determination of Tenofovir Fumarate and Emtricitabine in Bulk Powder and in Tablets

Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, University of Alexandria, Elmessalah 21521, Alexandria 21521, Egypt

Received 21 May 2013; Accepted 3 July 2013

Academic Editor: Lu Yang

Copyright © 2013 Mohammad H. AbdelHay et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. C. Sweetman, Ed., Martindale—The Complete Drug Reference, vol. 1, The Pharmaceutical Press, London, UK, 36th edition, 2009.
  2. A. R. Gennaro, Ed., Remington—The Science and Practice of Pharmacy, Lippincott Williams & Wilkins, Baltimore, Md, USA, 21st edition, 2005.
  3. A. C. Moffat, M. D. Osselton, and B. Widdop, Clark’s Analysis of Drugs and Poisons, vol. 2, The Pharmaceutical Press, London, UK, 3rd edition, 2004.
  4. M. C. Sharma, S. Sharma, and A. D. Sharma, “Hydrotropic solubilization phenomenon spectrophotometric estimation of Tenofovir disoproxil fumarate tablet,” Journal of Chemical and Pharmaceutical Research, vol. 2, no. 2, pp. 411–415, 2010. View at Google Scholar
  5. G. Gnanarajan, A. K. Gupta, V. Juyal, P. Kumar, P. K. Yadav, and P. Kailash, “A validated method for development of tenofovir as API and tablet dosage forms by UV spectroscopy,” Journal of Young Pharmacists, vol. 1, no. 4, pp. 351–353, 2009. View at Google Scholar
  6. A. Shirkhedkar Atul, H. Bhirud Charushila, and J. Surana Sanjay, “Application of UV-spectrophotometric methods for estimation of tenofovir disoproxil fumarate in tablets,” Pakistan Journal of Pharmaceutical Sciences, vol. 22, no. 1, pp. 27–29, 2009. View at Google Scholar · View at Scopus
  7. A. Shirkhedkar Atul, H. Bhirud Charushila, and J. Surana Sanjay, “Determination of tenofovir in pharmaceutical formulation by zero order and first order derivative UV-spectrophotometry methods,” Research Journal of Chemistry and Environment, vol. 12, no. 1, pp. 49–50, 2008. View at Google Scholar · View at Scopus
  8. A. A. Shirkhedkar, C. H. Bhirud, and S. J. Surana, “Determination of tenofovir in tablets by UV spectrophotometric and derivative spectrophotometric methods,” Oriental Journal of Chemistry, vol. 23, no. 3, pp. 1115–1118, 2007. View at Google Scholar
  9. K. V. Prakash, M. Padmalatha, and E. Dopadally, “Extractive spectrophotometric determination of tenofovir,” Biosciences Biotechnology Research Asia, vol. 7, no. 1, pp. 445–448, 2010. View at Google Scholar · View at Scopus
  10. S. M. Mallipatil, S. Noola, M. A. Nandedkar, P. S. Sarsambi, and A. Sonawane, “Spectrophotometric determination of tenofovir disoproxil fumarate,” International Journal of Chemical Sciences, vol. 8, no. 2, pp. 977–982, 2010. View at Google Scholar
  11. M. Majumder, B. Gopinath, G. Koni, and S. K. Singh, “New spectrophotometric determination of tinofovir in bulk and pharmaceutical dosage form,” E-Journal of Chemistry, vol. 6, no. 2, pp. 537–540, 2009. View at Google Scholar · View at Scopus
  12. N. Appala Raju, J. Venkateswara Rao, K. Vanitha Prakash, and K. Mukkanti, “Spectrophotometric estimation of tenofovir in pharmaceutical formulations,” Biosciences Biotechnology Research Asia, vol. 5, no. 1, pp. 439–442, 2008. View at Google Scholar · View at Scopus
  13. S. O. Choi, N. Rezk, J. S. Kim, and A. D. M. Kashuba, “Development of an LC-MS method for measuring TNF in human vaginal tissue,” Journal of Chromatographic Science, vol. 48, no. 3, pp. 219–223, 2010. View at Google Scholar · View at Scopus
  14. M. Yadav, T. Mishra, P. Singhal, S. Goswami, and P. S. Shrivastav, “Rapid and specific liquid chromatographic tandem mass spectrometric determination of tenofovir in human plasma and its fragmentation study,” Journal of Chromatographic Science, vol. 47, no. 2, pp. 140–148, 2009. View at Google Scholar · View at Scopus
  15. P. B. Kandagal, D. H. Manjunatha, J. Seetharamappa, and S. S. Kalanur, “RP-HPLC method for the determination of tenofovir in pharmaceutical formulations and spiked human plasma,” Analytical Letters, vol. 41, no. 4, pp. 561–570, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Takahashi, Y. Kudaka, N. Okumura, A. Hirano, K. Banno, and T. Kaneda, “Determination of plasma tenofovir concentrations using a conventional LC-MS method,” Biological and Pharmaceutical Bulletin, vol. 30, no. 9, pp. 1784–1786, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Bennetto-Hood, M. C. Long, and E. P. Acosta, “Development of a sensitive and specific liquid chromatography/mass spectrometry method for the determination of tenofovir in human plasma,” Rapid Communications in Mass Spectrometry, vol. 21, no. 13, pp. 2087–2094, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. T. King, L. Bushman, J. Kiser et al., “Liquid chromatography-tandem mass spectrometric determination of tenofovir-diphosphate in human peripheral blood mononuclear cells,” Journal of Chromatography B, vol. 843, no. 2, pp. 147–156, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Delahunty, L. Bushman, and C. V. Fletcher, “Sensitive assay for determining plasma tenofovir concentrations by LC/MS/MS,” Journal of Chromatography B, vol. 830, no. 1, pp. 6–12, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Ashenafi, V. Chintam, D. Van Veghel, S. Dragovic, J. Hoogmartens, and E. Adams, “Development of a validated liquid chromatographic method for the determination of related substances and assay of tenofovir disoproxil fumarate,” Journal of Separation Science, vol. 33, no. 12, pp. 1708–1716, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. Z. Ahmed, S. K. Shetty, B. Gopinath, M. Ahmed, and B. K. Sridhar, “Development and validation of RP-HPLC method for the determination of tenofovir disoproxil in bulk and in pharmaceutical formulation,” International Journal of Chemical Sciences, vol. 7, no. 4, pp. 2447–2458, 2009. View at Google Scholar
  22. S. M. Malipatil and M. A. Nandedkar, “Determination of Tenofovir disoproxil fumarate by a sensitive simple isocratic RP HPLC method,” Journal of Indian Council of Chemists, vol. 26, no. 1, pp. 67–69, 2009. View at Google Scholar
  23. S. Notari, A. Bocedi, G. Ippolito et al., “Simultaneous determination of 16 anti-HIV drugs in human plasma by high-performance liquid chromatography,” Journal of Chromatography B, vol. 831, no. 1-2, pp. 258–266, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Peepliwal and C. G. Bonde, “Determination of emtricitabine in human plasma by RP-HPLC with UV-detection,” Journal of Pharmacy Research, vol. 3, no. 8, pp. 1712–1715, 2010. View at Google Scholar
  25. J. A. H. Droste, R. E. Aarnoutse, and D. M. Burger, “Determination of emtricitabine in human plasma using HPLC with fluorometric detection,” Journal of Liquid Chromatography and Related Technologies, vol. 30, no. 18, pp. 2769–2778, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Rebiere, B. Mazel, C. Civade, and P.-A. Bonnet, “Determination of 19 antiretroviral agents in pharmaceuticals or suspected products with two methods using high-performance liquid chromatography,” Journal of Chromatography B, vol. 850, no. 1-2, pp. 376–383, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Pendela, D. A. Mamade, J. Hoogmartens, A. Van Schepdael, and E. Adams, “Characterization of emtricitabine related substances by liquid chromatography coupled to an ion trap mass spectrometer,” Talanta, vol. 82, no. 1, pp. 125–128, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Ashenafi, A. Verbeek, J. Hoogmartens, and E. Adams, “Development and validation of an LC method for the determination of emtricitabine and related compounds in the drug substance,” Journal of Separation Science, vol. 32, no. 11, pp. 1823–1830, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. U. Seshachalam, B. Haribabu, and K. B. Chandrasekhar, “Development and validation of a stability-indicating liquid chromatographic method for determination of emtricitabine and related impurities in drug substance,” Journal of Separation Science, vol. 30, no. 7, pp. 999–1004, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. V. R. Robledo and W. F. Smyth, “A study of the analytical behaviour of selected new molecular entities using electrospray ionisation ion trap mass spectrometry, liquid chromatography, gas chromatography and polarography and their determination in serum at therapeutic concentrations,” Analytica Chimica Acta, vol. 623, no. 2, pp. 221–230, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. N. L. Rezk, R. D. Crutchley, and A. D. M. Kashuba, “Simultaneous quantification of emtricitabine and tenofovir in human plasma using high-performance liquid chromatography after solid phase extraction,” Journal of Chromatography B, vol. 822, no. 1-2, pp. 201–208, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. N. A. Gomes, V. V. Vaidya, A. Pudage, S. S. Joshi, and S. A. Parekh, “Liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for simultaneous determination of tenofovir and emtricitabine in human plasma and its application to a bioequivalence study,” Journal of Pharmaceutical and Biomedical Analysis, vol. 48, no. 3, pp. 918–926, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Karunakaran, K. Kamarajan, and V. Thangarasu, “A validated RP-HPLC method for simultaneous estimation of emtricitabine and tenofovir disoproxil fumarate in pure and in tablet dosage form,” Pharmacia Sinica, vol. 1, no. 2, pp. 52–60, 2010. View at Google Scholar
  34. R. Sharma and P. Gupta, “A validated RP-HPLC method for simultaneous estimation of emtricitabine and tenofovir disoproxil fumarate in a tablet dosage form,” Eurasian Journal of Analytical Chemistry, vol. 4, no. 3, pp. 276–284, 2009. View at Google Scholar
  35. T. Delahunty, L. Bushman, B. Robbins, and C. V. Fletcher, “The simultaneous assay of tenofovir and emtricitabine in plasma using LC/MS/MS and isotopically labeled internal standards,” Journal of Chromatography B, vol. 877, no. 20-21, pp. 1907–1914, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. A. D. Avolio, M. Sciandra, M. Siccardi et al., “A new assay based on solid-phase extraction procedure with LC-MS to measure plasmatic concentrations of tenofovir and emtricitabine in HIV infected patients,” Journal of Chromatographic Science, vol. 46, no. 6, pp. 524–528, 2008. View at Google Scholar · View at Scopus
  37. K. D. Ingale, A. L. Barhate, A. N. Kale, C. D. Bobade, V. P. Choudhari, and B. S. Kuchekar, “Spectrophotometric estimation of emtricitabine and tenofovir disoproxil fumarate in tablet dosage form by simultaneous equation and absorbance ratio methods,” Journal of Pharmaceutical Research, vol. 9, no. 1, pp. 11–13, 2010. View at Google Scholar
  38. S. A. Ghorpade, M. S. Sali, A. H. Kategaonkar, D. M. Patel, V. P. Choudhari, and B. S. Kuchekar, “Simultaneous determination of emtricitabine and tenofovir by area under curve and dual wavelength spectrophotometric method,” Journal of the Chilean Chemical Society, vol. 55, no. 1, pp. 115–117, 2010. View at Google Scholar · View at Scopus
  39. M. Joshi, A. P. Nikalje, M. Shahed, and M. Dehghan, “HPTLC method for the simultaneous estimation of emtricitabine and tenofovir in tablet dosage form,” Indian Journal of Pharmaceutical Sciences, vol. 71, no. 1, pp. 95–97, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Yadav, P. Singhal, S. Goswami, U. C. Pande, M. Sanyal, and P. S. Shrivastav, “Selective determination of antiretroviral agents tenofovir, emtricitabine, and lamivudine in human plasma by a LC-MS-MS method for a bioequivalence study in healthy Indian subjects,” Journal of Chromatographic Science, vol. 48, no. 9, pp. 704–713, 2010. View at Google Scholar · View at Scopus
  41. T. Le Saux, S. Chhun, E. Rey et al., “Quantification of seven nucleoside/nucleotide reverse transcriptase inhibitors in human plasma by high-performance liquid chromatography with tandem mass-spectrometry,” Journal of Chromatography B, vol. 865, no. 1-2, pp. 81–90, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Senthilkumar, V. Shankarananth, K. K. Rajasekhar, K. S. Srinivas, R. Manikandan, and G. Kumar, “Method development and method validation for combination of anti-retroviral drugs,” Journal of Pharmacy Research, vol. 2, no. 10, pp. 1601–1605, 2009. View at Google Scholar
  43. V. P. Choudhari, S. Ingale, S. R. Gite, D. D. Tajane, V. G. Modak, and A. Ambekar, “Spectrophotometric simultaneous determination of tenofovir disoproxil fumarate and emtricitabine in combined tablet dosage form by ratio derivative, first order derivative and absorbance corrected methods and its application to dissolution study,” Pharmaceutical Methods, vol. 1, no. 2, pp. 47–52, 2011. View at Google Scholar
  44. ICH Harmonized Tripartite Guideline, Validation of Analytical Procedures, Text and Methodology, Q2(R1), International Conference on Harmonization, IFPMA, Geneva, Switzerland, 2005.